December 29, 2014 7:48 AM ET

Biotechnology

Company Overview of Ikaria, Inc.

Executive Profile

Daniel Tasse

Chairman, Chief Executive Officer and President, Ikaria, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 2 different industries.

See Board Relationships
54--

Background

Mr. Daniel Tassé served as the Chairman of the Board of Ikaria Holdings, Inc. (previously Ikaria, Inc.) since October 2009 and served as its Chief Executive Officer and President since January 2008. Mr. Tassé served as the General Manager of Baxter International's $2 billion Pharmaceuticals & Technologies business, a division created by integrating its Anesthesia, Critical Care and BioPharma Solutions Business units. Prior to his tenure at Baxter International, he held ...

Corporate Headquarters

Perryville III Corporate Park
Hampton, New Jersey 08827-9001

United States

Phone: 908-238-6600
Fax: 908-238-6633

Board Members Memberships

Director
Independent Non-Executive Director
2008-Present
Chairman, Chief Executive Officer and President

Education

BS
Universite De Montreal, L'

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ikaria, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.